Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; Department of Cardiology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
J Biol Chem. 2012 Jan 2;287(1):408-417. doi: 10.1074/jbc.M111.261818. Epub 2011 Nov 11.
Obesity-related diseases are associated with vascular dysfunction and impaired revascularization. Omentin is a fat-derived secreted protein, which is down-regulated in association with obese complications. Here, we investigated whether omentin modulates endothelial cell function and revascularization processes in vitro and in vivo. Systemic delivery of an adenoviral vector expressing omentin (Ad-omentin) enhanced blood flow recovery and capillary density in ischemic limbs of wild-type mice in vivo, which were accompanied by increased phosphorylation of Akt and endothelial nitric oxide synthase (eNOS). In cultured human umbilical vein endothelial cells (HUVECs), a physiological concentration of recombinant omentin protein increased differentiation into vascular-like structures and decreased apoptotic activity under conditions of serum starvation. Treatment with omentin protein stimulated the phosphorylation of Akt and eNOS in HUVECs. Inhibition of Akt signaling by treatment with dominant-negative Akt or LY294002 blocked the stimulatory effects of omentin on differentiation and survival of HUVECs and reversed omentin-stimulated eNOS phosphorylation. Pretreatment with the NOS inhibitor also reduced the omentin-induced increase in HUVEC differentiation and survival. Omentin protein also stimulated the phosphorylation of AMP-activated protein kinase in HUVECs. Transduction with dominant-negative AMP-activated protein kinase diminished omentin-induced phosphorylation of Akt and omentin-stimulated increase in HUVEC differentiation and survival. Of importance, in contrast to wild-type mice, systemic administration of Ad-omentin did not affect blood flow in ischemic muscle in eNOS-deficient mice in vivo. These data indicate that omentin promotes endothelial cell function and revascularization in response to ischemia through its ability to stimulate an Akt-eNOS signaling pathway.
肥胖相关疾病与血管功能障碍和再血管化受损有关。网膜素是一种脂肪衍生的分泌蛋白,与肥胖并发症有关的下调。在这里,我们研究了网膜素是否在体外和体内调节内皮细胞功能和再血管化过程。体内给予表达网膜素的腺病毒载体(Ad-omentin)可增强野生型小鼠缺血肢体的血流恢复和毛细血管密度,同时伴有 Akt 和内皮型一氧化氮合酶(eNOS)的磷酸化增加。在培养的人脐静脉内皮细胞(HUVECs)中,重组网膜素蛋白的生理浓度在血清饥饿条件下增加了血管样结构的分化,并减少了凋亡活性。用网膜素蛋白处理可刺激 HUVECs 中 Akt 和 eNOS 的磷酸化。用显性失活 Akt 或 LY294002 处理 Akt 信号转导抑制可阻断网膜素对 HUVEC 分化和存活的刺激作用,并逆转网膜素刺激的 eNOS 磷酸化。NOS 抑制剂的预处理也降低了网膜素诱导的 HUVEC 分化和存活增加。网膜素蛋白还刺激 HUVECs 中 AMP 激活的蛋白激酶的磷酸化。用显性失活 AMP 激活的蛋白激酶转导减弱了网膜素诱导的 Akt 磷酸化和网膜素刺激的 HUVEC 分化和存活增加。重要的是,与野生型小鼠相比,体内给予 Ad-omentin 对体内 eNOS 缺陷型小鼠缺血肌肉的血流没有影响。这些数据表明,网膜素通过刺激 Akt-eNOS 信号通路促进内皮细胞功能和再血管化以响应缺血。